Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
[Cancer Research 59, 793-797, February 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esteller, M.
Right arrow Articles by Herman, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esteller, M.
Right arrow Articles by Herman, J. G.
[Cancer Research 59, 793-797, February 15, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation is a Common Event in Primary Human Neoplasia1

Manel Esteller, Stanley R. Hamilton, Peter C. Burger, Stephen B. Baylin and James G. Herman2

Tumor Biology, The Johns Hopkins Oncology Center [M. E., S. B. B., J. G. H.], Division of GI-Liver Pathology [S. R. H.], and Department of Pathology [P. C. B.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231

The DNA repair protein O6-methylguanine DNA methyltransferase (MGMT) removes alkyl adducts from the O6 position of guanine. MGMT expression is decreased in some tumor tissues, and lack of activity has been observed in some cell lines. Loss of expression is rarely due to deletion, mutation, or rearrangement of the MGMT gene, but methylation of discrete regions of the CpG island of MGMT has been associated with the silencing of the gene in cell lines. We used methylation-specific PCR to study the promoter methylation of the MGMT gene. All normal tissues and expressing cancer cell lines were unmethylated, whereas nonexpressing cancer cell lines were methylated. Among the more than 500 primary human tumors examined, MGMT hypermethylation was present in a subset of specific types of cancer. In gliomas and colorectal carcinomas, aberrant methylation was detected in 40% of the tumors, whereas in non-small cell lung carcinomas, lymphomas, and head and neck carcinomas, this alteration was found in 25% of the tumors. MGMT methylation was found rarely or not at all in other tumor types. We also analyzed MGMT expression by immunohistochemistry in relation to the methylation status in 31 primary tumors. The presence of aberrant hypermethylation was associated with loss of MGMT protein, in contrast to retention of protein in the majority of tumors without aberrant hypermethylation. Our results suggest that epigenetic inactivation of MGMT plays an important role in primary human neoplasia.




This article has been cited by other articles:


Home page
 J. Mol. Diagn.Home page
A. J. Iafrate and D. N. Louis
"MGMT for pt mgmt": Is Methylguanine-DNA Methyltransferase Testing Ready for Patient Management?
J. Mol. Diagn., July 1, 2008; 10(4): 308 - 310.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
I. Vlassenbroeck, S. Califice, A.-C. Diserens, E. Migliavacca, J. Straub, I. Di Stefano, F. Moreau, M.-F. Hamou, I. Renard, M. Delorenzi, et al.
Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma
J. Mol. Diagn., July 1, 2008; 10(4): 332 - 337.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. N. Sarkaria, G. J. Kitange, C. D. James, R. Plummer, H. Calvert, M. Weller, and W. Wick
Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
Clin. Cancer Res., May 15, 2008; 14(10): 2900 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Suehiro, C. W. Wong, L. R. Chirieac, Y. Kondo, L. Shen, C. R. Webb, Y. W. Chan, A. S.Y. Chan, T. L. Chan, T.-T. Wu, et al.
Epigenetic-Genetic Interactions in the APC/WNT, RAS/RAF, and P53 Pathways in Colorectal Carcinoma
Clin. Cancer Res., May 1, 2008; 14(9): 2560 - 2569.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. D.F. Licchesi, W. H. Westra, C. M. Hooker, and J. G. Herman
Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung
Clin. Cancer Res., May 1, 2008; 14(9): 2570 - 2578.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. E. Sandercock, J. N. Hahn, L. Li, H.A. Luchman, J. L. Giesbrecht, L. A. Peterson, and F. R. Jirik
Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
Carcinogenesis, April 1, 2008; 29(4): 866 - 874.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Esteller
Epigenetics in Cancer
N. Engl. J. Med., March 13, 2008; 358(11): 1148 - 1159.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Zou, J. J. Harrington, A. M. Shire, R. L. Rego, L. Wang, M. E. Campbell, A. L. Oberg, and D. A. Ahlquist
Highly Methylated Genes in Colorectal Neoplasia: Implications for Screening
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2686 - 2696.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. M. Horton, P. A. Thompson, S. L. Berg, P. C. Adamson, A. M. Ingle, M. E. Dolan, S. M. Delaney, M. Hedge, H. L. Weiss, M.-F. Wu, et al.
Phase I Pharmacokinetic and Pharmacodynamic Study of Temozolomide in Pediatric Patients With Refractory or Recurrent Leukemia: A Children's Oncology Group Study
J. Clin. Oncol., November 1, 2007; 25(31): 4922 - 4928.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Fontijn, A. D. Adema, K. K. Bhakat, H. M. Pinedo, G. J. Peters, and E. Boven
O6-Methylguanine-DNA-methyltransferase promoter demethylation is involved in basic fibroblast growth factor induced resistance against temozolomide in human melanoma cells
Mol. Cancer Ther., October 1, 2007; 6(10): 2807 - 2815.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Schiff, P. D. Brown, and C. Giannini
Outcome in adult low-grade glioma: The impact of prognostic factors and treatment
Neurology, September 25, 2007; 69(13): 1366 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. Stupp, M. E. Hegi, M. R. Gilbert, and A. Chakravarti
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
J. Clin. Oncol., September 10, 2007; 25(26): 4127 - 4136.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
F. V. Jacinto and M. Esteller
Mutator pathways unleashed by epigenetic silencing in human cancer
Mutagenesis, July 1, 2007; 22(4): 247 - 253.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
T. Mikeska, C. Bock, O. El-Maarri, A. Hubner, D. Ehrentraut, J. Schramm, J. Felsberg, P. Kahl, R. Buttner, T. Pietsch, et al.
Optimization of Quantitative MGMT Promoter Methylation Analysis Using Pyrosequencing and Combined Bisulfite Restriction Analysis
J. Mol. Diagn., July 1, 2007; 9(3): 368 - 381.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Martinez, F. Setien, C. Voelter, S. Casado, M. P. Quesada, G. Schackert, and M. Esteller
CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme
Carcinogenesis, June 1, 2007; 28(6): 1264 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Eoli, F. Menghi, M. G. Bruzzone, T. De Simone, L. Valletta, B. Pollo, L. Bissola, A. Silvani, D. Bianchessi, L. D'Incerti, et al.
Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival
Clin. Cancer Res., May 1, 2007; 13(9): 2606 - 2613.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Esteller
Epigenetic gene silencing in cancer: the DNA hypermethylome
Hum. Mol. Genet., April 15, 2007; 16(R1): R50 - R59.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. J. Greenspan, J. L. Cyr, D. C. Pleau, J. Levine, T. V. Rajan, D. W. Rosenberg, and C. D. Heinen
Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer
Carcinogenesis, April 1, 2007; 28(4): 769 - 776.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
N P Lees, K L Harrison, C N Hall, G P Margison, and A C Povey
Human colorectal mucosal O6-alkylguanine DNA-alkyltransferase activity and DNA-N7-methylguanine levels in colorectal adenoma cases and matched referents
Gut, March 1, 2007; 56(3): 380 - 384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. W.K. Chiu, S. S.C. Chim, I. H.N. Wong, C. S.C. Wong, W.-S. Lee, K. F. To, J. H.M. Tong, R. K.C. Yuen, A. S.W. Shum, J. K.C. Chan, et al.
Hypermethylation of RASSF1A in Human and Rhesus Placentas
Am. J. Pathol., March 1, 2007; 170(3): 941 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. A. Righini, F. de Fraipont, J.-F. Timsit, C. Faure, E. Brambilla, E. Reyt, and M.-C. Favrot
Tumor-Specific Methylation in Saliva: A Promising Biomarker for Early Detection of Head and Neck Cancer Recurrence
Clin. Cancer Res., February 15, 2007; 13(4): 1179 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Wang, H. Liu, Z. Zhang, M. R. Spitz, and Q. Wei
Association of Genetic Variants of O6-Methylguanine-DNA Methyltransferase with Risk of Lung Cancer in Non-Hispanic Whites
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2364 - 2369.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. de Vogel, M. van Engeland, M. Luchtenborg, A. P. de Bruine, G. M. J. M. Roemen, M. H. F. M. Lentjes, R. A. Goldbohm, P. A. van den Brandt, A. F. P. M. de Goeij, and M. P. Weijenberg
Dietary Folate and APC Mutations in Sporadic Colorectal Cancer
J. Nutr., December 1, 2006; 136(12): 3015 - 3021.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. A. Hill, S. S. Wang, J. R. Cerhan, S. Davis, W. Cozen, R. K. Severson, P. Hartge, S. Wacholder, M. Yeager, S. J. Chanock, et al.
Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes
Blood, November 1, 2006; 108(9): 3161 - 3167.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
P Minoo, K Baker, R Goswami, G Chong, W D Foulkes, A R Ruszkiewicz, M Barker, D Buchanan, J Young, and J R Jass
Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis
Gut, October 1, 2006; 55(10): 1467 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
N. Auger, J. Thillet, K. Wanherdrick, A. Idbaih, M.-E. Legrier, B. Dutrillaux, M. Sanson, and M.-F. Poupon
Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line.
Mol. Cancer Ther., September 1, 2006; 5(9): 2182 - 2192.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T.-Y. Kim, S. Zhong, C. R. Fields, J. H. Kim, and K. D. Robertson
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
Cancer Res., August 1, 2006; 66(15): 7490 - 7501.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. P. Fruehauf, H. Brem, S. Brem, A. Sloan, G. Barger, W. Huang, and R. Parker
In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas
Clin. Cancer Res., August 1, 2006; 12(15): 4523 - 4532.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
Y. Berger, C. C. Bernasconi, and L. Juillerat-Jeanneret
Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1111 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Furlan, I. Carnevali, B. Marcomini, R. Cerutti, E. Dainese, C. Capella, and C. Riva
The High Frequency of De novo Promoter Methylation in Synchronous Primary Endometrial and Ovarian Carcinomas.
Clin. Cancer Res., June 1, 2006; 12(11): 3329 - 3336.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Ibanez de Caceres, E. Dulaimi, A. M. Hoffman, T. Al-Saleem, R. G. Uzzo, and P. Cairns
Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
Cancer Res., May 15, 2006; 66(10): 5021 - 5028.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Hunter, R. Smith, D. P. Cahill, P. Stephens, C. Stevens, J. Teague, C. Greenman, S. Edkins, G. Bignell, H. Davies, et al.
A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy.
Cancer Res., April 15, 2006; 66(8): 3987 - 3991.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Ishiguro, H. A. Seow, P. G. Penketh, K. Shyam, and A. C. Sartorelli
Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine.
Mol. Cancer Ther., April 1, 2006; 5(4): 969 - 976.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
E. J. Fox, D. T. Leahy, R. Geraghty, H. E. Mulcahy, D. Fennelly, J. M. Hyland, D. P. O'Donoghue, and K. Sheahan
Mutually Exclusive Promoter Hypermethylation Patterns of hMLH1 and O6-Methylguanine DNA Methyltransferase in Colorectal Cancer
J. Mol. Diagn., February 1, 2006; 8(1): 68 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K.-W. Jair, K. E. Bachman, H. Suzuki, A. H. Ting, I. Rhee, R.-W. C. Yen, S. B. Baylin, and K. E. Schuebel
De novo CpG Island Methylation in Human Cancer Cells
Cancer Res., January 15, 2006; 66(2): 682 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. T. McCabe, J. A. Low, S. Daignault, M. J. Imperiale, K. J. Wojno, and M. L. Day
Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer
Cancer Res., January 1, 2006; 66(1): 385 - 392.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
Y. T. Kim, S. J. Park, S. H. Lee, H. J. Kang, S. Hahn, C. H. Kang, S. W. Sung, and J. H. Kim
Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung
J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1378 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Ishiguro, K. Shyam, P. G. Penketh, and A. C. Sartorelli
Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine
Mol. Cancer Ther., November 1, 2005; 4(11): 1755 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. B. Makarla, M. H. Saboorian, R. Ashfaq, K. O. Toyooka, S. Toyooka, J. D. Minna, A. F. Gazdar, and J. O. Schorge
Promoter Hypermethylation Profile of Ovarian Epithelial Neoplasms
Clin. Cancer Res., August 1, 2005; 11(15): 5365 - 5369.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Brell, A. Tortosa, E. Verger, J. M. Gil, N. Vinolas, S. Villa, J. J. Acebes, L. Caral, T. Pujol, I. Ferrer, et al.
Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas
Clin. Cancer Res., July 15, 2005; 11(14): 5167 - 5174.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Halford, A Rowan, E Sawyer, I Talbot, and I Tomlinson
O6-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions
Gut, June 1, 2005; 54(6): 797 - 802.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
Y. Koga, Y. Kitajima, A. Miyoshi, K. Sato, K. Kitahara, H. Soejima, and K. Miyazaki
Tumor Progression Through Epigenetic Gene Silencing of O6-Methylguanine-DNA Methyltransferase in Human Biliary Tract Cancers
Ann. Surg. Oncol., May 1, 2005; 12(5): 354 - 363.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. R.J. Kohonen-Corish, J. J. Daniel, C. Chan, B. P.C. Lin, S. Y. Kwun, O. F. Dent, V. S. Dhillon, R. J.A. Trent, P. H. Chapuis, and E. L. Bokey
Low Microsatellite Instability Is Associated With Poor Prognosis in Stage C Colon Cancer
J. Clin. Oncol., April 1, 2005; 23(10): 2318 - 2324.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Y. T. Kim, S. H. Lee, S. W. Sung, and J. H. Kim
Can Aberrant Promoter Hypermethylation of CpG Islands Predict the Clinical Outcome of Non-Small Cell Lung Cancer After Curative Resection?
Ann. Thorac. Surg., April 1, 2005; 79(4): 1180 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
R. Meuwissen and A. Berns
Mouse models for human lung cancer
Genes & Dev., March 15, 2005; 19(6): 643 - 664.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. E. Hegi, A.-C. Diserens, T. Gorlia, M.-F. Hamou, N. de Tribolet, M. Weller, J. M. Kros, J. A. Hainfellner, W. Mason, L. Mariani, et al.
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
N. Engl. J. Med., March 10, 2005; 352(10): 997 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
T. Osanai, Y. Takagi, Y. Toriya, T. Nakagawa, T. Aruga, S. Iida, H. Uetake, and K. Sugihara
Inverse Correlation Between the Expression of O6-Methylguanine-DNA Methyl Transferase (MGMT) and p53 in Breast Cancer
Jpn. J. Clin. Oncol., March 1, 2005; 35(3): 121 - 125.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
R. P. Danam, S. R. Howell, T. P. Brent, and L. C. Harris
Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins
Mol. Cancer Ther., January 1, 2005; 4(1): 61 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Guo, Y. Akiyama, M. G. House, C. M. Hooker, E. Heath, E. Gabrielson, S. C. Yang, Y. Han, S. B. Baylin, J. G. Herman, et al.
Hypermethylation of the GATA Genes in Lung Cancer
Clin. Cancer Res., December 1, 2004; 10(23): 7917 - 7924.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. Kaina, U. Muhlhausen, A. Piee-Staffa, M. Christmann, R. Garcia Boy, F. Rosch, and R. Schirrmacher
Inhibition of O6-Methylguanine-DNA Methyltransferase by Glucose-Conjugated Inhibitors: Comparison with Nonconjugated Inhibitors and Effect on Fotemustine and Temozolomide-Induced Cell Death
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 585 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. K. Leung, K.-F. To, E. P.S. Man, M. W.Y. Chan, A. H.C. Bai, A. J. Hui, F. K.L. Chan, J. F.Y. Lee, and J. J. Y. Sung
Detection of Epigenetic Changes in Fecal DNA as a Molecular Screening Test for Colorectal Cancer: A Feasibility Study
Clin. Chem., November 1, 2004; 50(11): 2179 - 2182.
[Full Text] [PDF]

Home page
 GutHome page
T Kambara, L A Simms, V L J Whitehall, K J Spring, C V A Wynter, M D Walsh, M A Barker, S Arnold, A McGivern, N Matsubara, et al.
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
Gut, August 1, 2004; 53(8): 1137 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. F. Paz, R. Yaya-Tur, I. Rojas-Marcos, G. Reynes, M. Pollan, L. Aguirre-Cruz, J. L. Garcia-Lopez, J. Piquer, M.-J. Safont, C. Balana, et al.
CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas
Clin. Cancer Res., August 1, 2004; 10(15): 4933 - 4938.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
B. R. Rood, H. Zhang, and P. H. Cogen
Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma
Neuro-oncol, July 1, 2004; 6(3): 200 - 207.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
N. P. Lees, K. L. Harrison, C. N. Hall, G. P. Margison, and A. C. Povey
Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC->AT transition mutations in a population exposed to methylating agents
Carcinogenesis, July 1, 2004; 25(7): 1243 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Pellise, A. Castells, A. Gines, R. Agrelo, M. Sole, S. Castellvi-Bel, G. Fernandez-Esparrach, J. Llach, M. Esteller, J. M. Bordas, et al.
Detection of Lymph Node Micrometastases by Gene Promoter Hypermethylation in Samples Obtained by Endosonography- Guided Fine-Needle Aspiration Biopsy
Clin. Cancer Res., July 1, 2004; 10(13): 4444 - 4449.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Dulaimi, I. I. de Caceres, R. G. Uzzo, T. Al-Saleem, R. E. Greenberg, T. J. Polascik, J. S. Babb, W. E. Grizzle, and P. Cairns
Promoter Hypermethylation Profile of Kidney Cancer
Clin. Cancer Res., June 15, 2004; 10(12): 3972 - 3979.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Zuo, L. Ai, P. Ratliff, J. Y. Suen, E. Hanna, T. P. Brent, and C.-Y. Fan
O6-Methylguanine-DNA Methyltransferase Gene: Epigenetic Silencing and Prognostic Value in Head and Neck Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 967 - 975.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. G. HERMAN
Circulating Methylated DNA
Ann. N.Y. Acad. Sci., June 1, 2004; 1022(1): 33 - 39.
[Abstract] [Full Text] [PDF]